With just three days left in Erowid's annual public support drive,
we're 338 donations short of our end-of-month goal.
Donations $5 and higher are being doubled, tripled or quadrupled by
a matching challenge! We still have $25,000 in matching funds
available. Take a moment to support the evolution of accurate,
fact-based information about psychoactive drugs with a small
donation, and help us make this a successful drive:
http://erowid.org/sept_drive
Horizons NYC
(Oct 9-11, 2015) in New York City
With presenters discussing psychedelic research, cognitive liberty,
drug policy, and more, this annual New York event offers something
for everyone.
http://horizonsnyc.org/
|
Ergoloids (AL-LAD and LSZ), an indole derivative (5-IT),
phenethylamine relatives (2C-EF and TCB-2), an entactogen (5-MAPB),
and benzodiazepines (flubromazepam and pyrazolam) are representative
of a broad range of novel compounds hitting the marketplace in recent
years.
|
|
Searchable, transcribed PDF of Dr. Alexander Shulgin's Pharmacology
Notebook #6, covering 1983-1984. The Pharmacology notebooks contain
reports and trials that were used as source material for PiHKAL
and TiHKAL, including details and information never before
published. Thanks to Shawn for his continued work on this project!
|
|
During its peak, the Hive was one of the most influential web forums
covering chemistry, synthesis, and pharmacology of psychoactive
chemicals. Active 1997-2004, it had thousands of members and was
infamous for its groundbreakingly detailed and explicit discussions.
This long-awaited read-only snapshot is fully functional, with
private info redacted.
|
-
A highly technical multi-year analysis of grey-market research
chemicals using NMR (Nuclear Magnetic Resonance), an extremely
precise method for identifying substances. Excellent, world-class
work by Stephen Chapman and Arabo Avanes. IsomerDesign is a sponsor
of Erowid Center's EcstasyData project.
-
An EcstasyData update that first appeared in Extracts; gives an
overview of this Erowid project's objectives and trends.
Utilization of EcstasyData continues to increase and transform
since the early days of tablet-only testing.
-
Information about the relatively new research chemical and euphoric
stimulant also known as "Flakka". Includes info about its history,
legal status, and chemistry.
-
One of the important ongoing tasks at Erowid is to maintain the
servers that make our online resources available to almost
20 million unique visitors each year.
-
After years of quietly working on anti-depressants, cognitive
enhancers, and psychedelics, Erowid and Team Shulgin are pleased to
present the story of a previously low profile member of the
unapproved research community.
EcstasyData is a project of Erowid Center that conducts laboratory
testing of street ecstasy tablets, research chemicals, and other
drugs, and publishes the results online.
2015 will have the highest number of analyzed samples in the history
of the project.
Contains Alpha-PVP (aka Flakka), which has been found in samples
sold as Ecstasy/Molly, and the fluorinated amphetamines.
A yellow ecstasy-like tablet containing the psychedelic 25I-NBOMe.
If you find Erowid a useful resource and are interested in supporting
its future development, please consider donating or becoming a member.
Donations to Erowid Center are tax-deductible in the United States.
- To UNSUBSCRIBE - send an empty email to: e_announce-unsubscribe@erowid.org
- To SUBSCRIBE - send an empty email to: e_announce-subscribe@erowid.org
|
|
